George W. LeMaitre - 10 Dec 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: Chairman and CEO, Director
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol: LMAT
Transactions as of: 10 Dec 2025
Transactions value $: $0
Form type: 4
Filing time: 11 Dec 2025, 18:10:27 UTC
Previous filing: 10 Dec 2025
Next filing: 15 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
LeMaitre George W	Chairman and CEO, Director	C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON	/s/ Laurie A. Churchill, Attorney-in-fact	11 Dec 2025	0001365737

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Award	$0	+6.28K	+0.38%	$0.00	1.67M	10 Dec 2025	Direct	F1
holding	LMAT	Common Stock						21.3K	10 Dec 2025	LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Stock Option (Right to Buy)	Award	$0	+38.5K		$0.00	38.5K	10 Dec 2025	Common Stock	38.5K	$83.66	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining three years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
F2	These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
F3	This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining three years.